A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

T Kühr; S Burgstaller; U Apfelbeck; W Linkesch; H Seewann; M Fridrik; G Michlmayr; O Krieger; D Lutz; W Lin; J Pont; L Köck; K Abbrederis; C Baldinger; R Buder; D Geissler; H Hausmaninger; A Lang; A Zabernigg; C Duba; W Hilbe; W Eisterer; M Fiegl; Richard Greil; G Gastl; J Thaler

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch, H Seewann, M Fridrik, G Michlmayr, O Krieger, D Lutz, W Lin, J Pont, L Köck, K Abbrederis, C Baldinger, R Buder, D Geissler, H Hausmaninger, A Lang, A Zabernigg, C DubaW Hilbe, W Eisterer, M Fiegl, Richard Greil, G Gastl, J Thaler

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

16 Citations (Web of Science)

Original language	English
Pages (from-to)	405-411
Journal	LEUKEMIA RESEARCH
Volume	27
Issue number	5
Publication status	Published - 2003

Keywords

CHRONIC MYELOGENOUS LEUKEMIA
CYTOGENETIC RESPONSE
BUSULFAN
CHEMOTHERAPY
SURVIVAL
THERAPY
ALFA-2A
TRIAL

Cite this

Kühr, T., Burgstaller, S., Apfelbeck, U., Linkesch, W., Seewann, H., Fridrik, M., Michlmayr, G., Krieger, O., Lutz, D., Lin, W., Pont, J., Köck, L., Abbrederis, K., Baldinger, C., Buder, R., Geissler, D., Hausmaninger, H., Lang, A., Zabernigg, A., ... Thaler, J. (2003). A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). LEUKEMIA RESEARCH , 27(5), 405-411.

Kühr, T ; Burgstaller, S ; Apfelbeck, U et al. / A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). In: LEUKEMIA RESEARCH 2003 ; Vol. 27, No. 5. pp. 405-411.

@article{66de6c1e4c6844ad92264181351228aa,

title = "A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).",

keywords = "CHRONIC MYELOGENOUS LEUKEMIA, CYTOGENETIC RESPONSE, BUSULFAN, CHEMOTHERAPY, SURVIVAL, THERAPY, ALFA-2A, TRIAL",

author = "T K{\"u}hr and S Burgstaller and U Apfelbeck and W Linkesch and H Seewann and M Fridrik and G Michlmayr and O Krieger and D Lutz and W Lin and J Pont and L K{\"o}ck and K Abbrederis and C Baldinger and R Buder and D Geissler and H Hausmaninger and A Lang and A Zabernigg and C Duba and W Hilbe and W Eisterer and M Fiegl and Richard Greil and G Gastl and J Thaler",

year = "2003",

language = "English",

volume = "27",

pages = "405--411",

journal = "LEUKEMIA RESEARCH ",

issn = "0145-2126",

number = "5",

}

Kühr, T, Burgstaller, S, Apfelbeck, U, Linkesch, W, Seewann, H, Fridrik, M, Michlmayr, G, Krieger, O, Lutz, D, Lin, W, Pont, J, Köck, L, Abbrederis, K, Baldinger, C, Buder, R, Geissler, D, Hausmaninger, H, Lang, A, Zabernigg, A, Duba, C, Hilbe, W, Eisterer, W, Fiegl, M, Greil, R, Gastl, G & Thaler, J 2003, 'A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).', LEUKEMIA RESEARCH , vol. 27, no. 5, pp. 405-411.

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). / Kühr, T; Burgstaller, S; Apfelbeck, U et al.
In: LEUKEMIA RESEARCH , Vol. 27, No. 5, 2003, p. 405-411.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

AU - Kühr, T

AU - Burgstaller, S

AU - Apfelbeck, U

AU - Linkesch, W

AU - Seewann, H

AU - Fridrik, M

AU - Michlmayr, G

AU - Krieger, O

AU - Lutz, D

AU - Lin, W

AU - Pont, J

AU - Köck, L

AU - Abbrederis, K

AU - Baldinger, C

AU - Buder, R

AU - Geissler, D

AU - Hausmaninger, H

AU - Lang, A

AU - Zabernigg, A

AU - Duba, C

AU - Hilbe, W

AU - Eisterer, W

AU - Fiegl, M

AU - Greil, Richard

AU - Gastl, G

AU - Thaler, J

PY - 2003

Y1 - 2003

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - CYTOGENETIC RESPONSE

KW - BUSULFAN

KW - CHEMOTHERAPY

KW - SURVIVAL

KW - THERAPY

KW - ALFA-2A

KW - TRIAL

M3 - Original Article

C2 - 12620292

SN - 0145-2126

VL - 27

SP - 405

EP - 411

JO - LEUKEMIA RESEARCH

JF - LEUKEMIA RESEARCH

IS - 5

ER -

Kühr T, Burgstaller S, Apfelbeck U, Linkesch W, Seewann H, Fridrik M et al. A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). LEUKEMIA RESEARCH . 2003;27(5):405-411.